Moreover, GBM microenvironment is enriched with GM-CSF, which acts on glioma-infiltrating myeloid cells and promotes immunosuppression through the upregulation of IL-4, an anti-inflammatory cytokine [67]. The gene discussed is IL4; the disease is central nervous system cancer.